Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1P 140----[1] 49
2P-1037----[1] 299
3P-188 NF----[1] 113
4P-552----[1] 53
5P144----[1] 51
6P144 cream----[1] 51
7P144 Cytokine Inhibitor----[1] 51
8P144 Cytokines Inhibitors----[1] 51
9P144 DIGNA CREAM----[1] 51
10P144. Cytokines Inhibitors----[1] 51
11P28GST----[1] 96
12P2B001----[1] 6
13P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),[2] Pramipexole,
Rasagiline		[3] D05575 ,
D08469 ,
D10829 		[4] DRD2,
DRD3,
DRD4,
MAOB 💬		[18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
14P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),[2] Pramipexole,
Rasagiline		[3] D05575 ,
D08469 ,
D10829 		[4] DRD2,
DRD3,
DRD4,
MAOB 💬		[18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
15P32----[1] 37
16P32/98----[1] 37
17P32/98 3%----[1] 37
18P38 (4) Map Kinase Inhibitor----[1] 46
19P38 Inhibitor (4)----[1] 46
20P38 Inhibitor (4) 150mg----[1] 46
21P38 Inhibitor (4) 25mg----[1] 46
22P38 Inhibitor (4) 300mg----[1] 46
23P38 Inhibitor (4) 50mg----[1] 46
24P38 Inhibitor (4) 75mg----[1] 46
25P38 Map Kinase Inhibitor----[1] 46
26P38(4) Map Kinase Inhibitor----[1] 46
27PA101----[1] 85
28PAAG15----[1] 299
29Pabinafusp alfa[1] Pabinafusp alfa[1] D11812 [2] IDS,
TFRC 💬		[8] Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬[1] 19
30Paclitaxel[1] Paclitaxel[1] D00491 [9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[2] 46, 85
31Padsevonil[1] Padsevonil[1] D11842 [3] SV2A,
SV2B,
SV2C 💬		[1] ECM-receptor interaction 💬[1] 149
32PAH----[3] 49, 53, 86
33PAH medication----[1] 86
34PAH Therapies----[1] 86
35Palifermin[1] Palifermin[1] D05338 [1] FGFR2 💬[13] Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[5] 13, 36, 38, 39, 65
36Palmitate[1] Palmitic Acid[1] D05341 --[1] 63
37Palmitoleic Acid[1] Palmitoleic Acid---[1] 97
38Palmitoylethanolamide[1] Palmidrol[1] D08328 --[1] 2
39Palopegteriparatide----[1] 235
40Palopegteriparatide (TransCon PTH)----[1] 235
41PALOVAROTENE[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
42PALOVAROTENE - 1.5mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
43PALOVAROTENE - 10 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
44PALOVAROTENE - 1mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
45PALOVAROTENE - 2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
46PALOVAROTENE - 2.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
47PALOVAROTENE - 3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
48PALOVAROTENE - 4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
49PALOVAROTENE - 5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
50PALOVAROTENE 1.5 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
51Palovarotene dose level 1[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
52Palovarotene dose level 2[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
53Palovarotene dose level 3[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
54Palovarotene dose level 4[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
55PALOVAROTENE-2 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
56PALOVAROTENE-3 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
57PALOVAROTENE-4 mg[1] Palovarotene[1] D09365 [1] RARG 💬-[1] 272
58Palynziq[1] Pegvaliase[1] D11077 [1] PAH 💬[5] Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬[1] 240
59Pamidronate[1] Pamidronic acid[1] D07281 [1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 270, 271, 274
60Pamidronate (Aredia)[1] Pamidronic acid[1] D07281 [1] FDPS 💬[4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 274
61PAMREVLUMAB[1] Pamrevlumab[1] D10969 [1] CCN2 💬[2] Apelin signaling pathway, Hippo signaling pathway 💬[2] 85, 113
62Pamrevlumab (FG-3019)[1] Pamrevlumab[1] D10969 [1] CCN2 💬[2] Apelin signaling pathway, Hippo signaling pathway 💬[1] 113
63Panax Quinquefolius[1] Panax quinquefolius whole---[1] 46
64Pancreas Powder----[1] 299
65Pancrease----[1] 299
66PANCREASE MT----[1] 299
67Pancrease MT 10.5, or MT 21----[1] 299
68PANCREASLIPASE----[1] 299
69Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)[2] Acarbose,
Pancrelipase		[2] D00216 ,
D05349 		[5] AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		[7] Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬[1] 298
70Pancreatic enzymes----[1] 298
71Pancreatin[1] Pancrelipase[1] D05349 --[2] 298, 299
72PANCREATIN (PAncreas Powder)[1] Pancrelipase[1] D05349 --[1] 299
73PANCREATINA----[1] 299
74PANCREATINA (Páncreas Polvo----[1] 299
75PANCREATINA (Páncreas Polvo)----[1] 299
76PANCREAZE----[1] 299
77PANCREAZE®----[1] 299
78PANCRECARB® (pancrelipase)[1] Pancrelipase[1] D05349 --[1] 299
79Pancrelipase[1] Pancrelipase[1] D05349 --[2] 298, 299
80PANCRELIPASE AMYLASE[1] Pancrelipase[1] D05349 --[1] 299
81Pancrelipase Delayed Release[1] Pancrelipase[1] D05349 --[1] 299
82Pancrelipase Delayed Release Capsule[1] Pancrelipase[1] D05349 --[2] 298, 299
83Pancrelipase Microtablets[1] Pancrelipase[1] D05349 --[1] 299
84Pancrelipase with bicarbonate[1] Pancrelipase[1] D05349 --[1] 299
85Pancrelipase/Pancreas Powder[1] Pancrelipase[1] D05349 --[2] 298, 299
86Pandemrix,----[1] 46
87Panhematin[1] Hemin[1] D10003 [2] ALAS1,
ALAS2 💬		[4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬[1] 254
88Pankreatin----[1] 299
89Pantethine[1] Pantethine[1] D01234 --[1] 120
90Pantoprazole[1] Pantoprazole[1] D05353 [2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[2] 13, 65
91Pantoprazolo 20 mg gastro-resistant tablets----[1] 65
92PANZYGA----[1] 14
93Panzytrat----[1] 298
94Panzytrat 25.000----[1] 298
95Panzytrat 25.000 FIP-E units of Lipase----[1] 298
96PANZYTRAT 25000----[1] 299
97Panzytrat® 25,000----[1] 299
98Panzytrat® ok----[1] 299
99Paquinimod[1] Paquinimod---[2] 49, 51
100Paquinimod (ABR-215757)[1] Paquinimod---[1] 49
101PARACETAMOL[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[6] 3, 6, 13, 35, 46, 49
102Paracetamol (acetaminophen)[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
103Paracetamol 120Mg/5mL Oral Suspension[1] Acetaminophen[1] D00217 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 3
104PARACETAMOLO----[9] 2, 11, 14, 19, 28, 53, 61, 63, 300
105Paracetamolo 500 mg----[1] 13
106PARACETAMOLO DC.IT FU----[1] 46
107PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE----[1] 19
108PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----[1] 300
109Paracetamolo Zentiva Italia----[1] 28
110Paraclisib----[1] 61
111Paraffin Oil[1] Mineral oil[1] D05042 --[1] 291
112PARALEN 500----[1] 46
113Parapres----[1] 6
114Parathyroid hormon 1-84----[1] 235
115Parathyroid hormone[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[2] 70, 235
116Parathyroid Hormone (1-84) Human Recombinant[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
117Parathyroid Hormone (rDNA)[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
118Parathyroideahormon----[1] 235
119PARCOPA----[1] 6
120Pardaprunox----[1] 6
121Pardoprunox[1] Pardoprunox[1] D09397 [3] DRD2,
DRD3,
HTR1A 💬		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6
122Pardoprunox hydrochloride[1] Pardoprunox[1] D09397 [3] DRD2,
DRD3,
HTR1A 💬		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬[1] 6
123Parecoxib[1] Parecoxib[1] D03716 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
124Parenteral Remodulin (treprostinil) injection[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
125Parenteral Treprostinil[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
126Paricalcitol[1] Paricalcitol[1] D00930 [1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[5] 19, 66, 218, 238, 298
127Parnaparin[1] Parnaparin[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[1] 97
128PARNAPARIN SODIUM[1] Parnaparin[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[1] 97
129Paroxetine[1] Paroxetine[1] D02362 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 6, 13, 46, 85
130Paroxetine & Prednisolone[2] Paroxetine,
Prednisolone		[2] D00472 ,
D02362 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
131Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP[2] Paroxetine,
Prednisolone		[2] D00472 ,
D02362 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
132Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP[2] Paroxetine,
Prednisolone		[2] D00472 ,
D02362 		[2] NR3C1,
SLC6A4 💬		[3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46
133Parsaclisib[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[3] 35, 53, 61
134Parsaclisib (1 mg)[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[1] 61
135Parsaclisib (2.5 mg)[1] Parsaclisib[1] D11437 [1] PIK3CD 💬[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[1] 61
136Parsaclisinib----[1] 61
137Part 1 Levulan injection----[1] 34
138Part 1 Levulan surface application----[1] 34
139Part 1 Levulan surface application twice----[1] 34
140Part 1 Levulan surface application twice with microneedling----[1] 34
141Part 1, JM-010 component Group A----[1] 6
142Part 1, JM-010 component Group B----[1] 6
143Part 1, JM-010 component Group C----[1] 6
144Part 1: LJN452----[1] 93
145Part 2 Adult Alogabat High Dose (aged 15-17)----[1] 201
146Part 2, JM-010 combination Group A----[1] 6
147Part 2, JM-010 combination Group B----[1] 6
148Part 2, JM-010 component Group C----[1] 6
149Part 2: LJN452 Dose level 1----[1] 93
150Part 2: LJN452 Dose level 2----[1] 93
151Part A----[1] 46
152Part A: 100 mg/mL GSK2618960----[1] 13
153Part B----[1] 46
154Part B Open-Label Extension----[1] 51
155Part B: Dose of GSK2618960 decided from Part A----[1] 13
156Part C: Dose of GSK2618960 decided from Part A and B----[1] 13
157Part I - etoricoxib 60 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
158Part I - etoricoxib 90 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
159Part I- naproxen 1000 mg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
160Part II- etoricoxib 60 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
161Part II- etoricoxib 90 mg[1] Etoricoxib[1] D03710 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
162Part II- naproxen 1000 mg[1] Naproxen[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
163Partial Enteral Nutrition----[1] 96
164Pasireotida[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
165Pasireotida 300[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
166Pasireotida 600[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
167Pasireotida 900[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
168Pasireotide[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 74, 75
169Pasireotide 0.3mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
170Pasireotide 0.6 MG/ML[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
171Pasireotide 0.6mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
172Pasireotide 0.9 mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
173Pasireotide 20mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
174Pasireotide 40mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
175Pasireotide 60mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
176PASIREOTIDE DIASPARTATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
177Pasireotide LAR[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 75
178PASIREOTIDE PAMOATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
179Pasireotide s.c.[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
180Pasireotide sub-cutaneous[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
181Pasireotide with or without cabergoline[2] Cabergoline,
Pasireotide		[2] D00987 ,
D10147 		[6] DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 75
182Pasireotode----[1] 75
183PAT----[1] 160
184PAT-001, 0.1%----[1] 160
185PAT-001, 0.2%----[1] 160
186Patient Current Care----[1] 46
187Patient treated with DMARD----[1] 46
188Patients will be randomized to receive EHP-101----[1] 51
189Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----[1] 46
190Pazopanib[1] Pazopanib---[1] 227
191PB----[2] 67, 225
192PB006----[1] 13
193PB1046----[1] 86
194PB1046 Injection----[1] 113
195PB1046 Subcutaneous Injection----[1] 86
196PB1046, VIP-ELP1-120, Vasomera----[1] 86
197PBA----[1] 231
198PBF-509----[1] 6
199PBF-677----[1] 97
200PBF-999----[1] 8
201PBF-999 / 160 mg----[1] 8
202PBF-999 / 320 mg----[1] 8
203PBFT02----[1] 127
204PBGM01----[1] 19
205PBI4050----[2] 85, 299
206PBKR03----[1] 19
207PBMC autotransplantation----[1] 2
208PBT2----[1] 8
209PC945----[1] 299
210PCA----[1] 70
211PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----[1] 65
212PCO371----[1] 235
213PCR polymorphism----[1] 46
214PCT (PureCell Technologies Complex)----[1] 97
215PCV----[1] 13
216PD 0299685----[1] 226
217PD 0299685 at 15mg BID----[1] 226
218PD 0299685 at 30mg BID----[1] 226
219PD 0360324----[2] 46, 84
220PD patients H&Y=1.5-2 Medications OFF----[1] 6
221PD patients H&Y=1.5-2 Medications ON----[1] 6
222PD patients H&Y=3 Medications OFF----[1] 6
223PD patients H&Y=3 Medications ON----[1] 6
224PD vitamin supplementation----[1] 6
225PD-0299685[1] PD-0299685---[1] 226
226PD-0325901[1] Mirdametinib[1] D11675 [2] MAP2K1,
MAP2K2 💬		[89] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34
227PD00377 Na-salt----[1] 85
228PDA001----[2] 46, 96
229PDA001 (cenplacel-L)----[1] 84
230PDE5 inhibitor----[1] 86
231PEA-LUT----[1] 127
232Pectin[1] Pectin[1] D02316 --[1] 96
233Pednisone----[2] 43, 44
234Peficitinib[1] Peficitinib[1] D10653 [3] JAK1,
JAK2,
JAK3 💬		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
235PEG----[15] 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337
236Peg-Ada----[1] 65
237Peg-Interferon alpha-2b[1] Interferon alfa-2b[1] D02745 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 34
238PEG-interleukin-2[1] Human interleukin-2---[1] 65
239PEG-liposomal Prednisolone Sodium Phosphate[2] Phosphate ion,
Prednisolone		[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 13, 97
240PEG-rhG-CSF----[1] 60
241PEG-somatropin[1] Somatotropin---[1] 78
242Pegcetacoplam----[1] 2
243PEGCETACOPLAN[1] Pegcetacoplan[1] D11613 [1] C3 💬[17] Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬[4] 2, 61, 62, 222
244Pegcetacoplan (APL-2)[1] Pegcetacoplan[1] D11613 [1] C3 💬[17] Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬[3] 2, 61, 62
245Pegfilgrastim[1] Pegfilgrastim[1] D06889 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 60
246Peginesatide[1] Peginesatide[1] D09946 [1] EPOR 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 283
247PEGINTERFERON BETA-1A[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
248Peginterferone beta 1a----[1] 13
249PEGINTERFERONE BETA-1A----[1] 13
250PEGINTERFERONE LAMBDA-1A----[1] 13
251Pegsunercept[1] Pegsunercept[1] D05393 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
252Pegsunercept (PEG sTNF-RI)[1] Pegsunercept[1] D05393 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
253Pegtarviliase----[1] 337
254Pegtibatinase----[1] 337
255PEGUNIGALSIDASE ALFA[1] Pegunigalsidase alfa[1] D11685 --[1] 19
256Pegunigalsidase alpha----[1] 19
257PEGVALIASE[1] Pegvaliase[1] D11077 [1] PAH 💬[5] Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬[1] 240
258Pegvaliase-Pqpz[1] Pegvaliase[1] D11077 [1] PAH 💬[5] Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬[1] 240
259Pegvisomant[1] Pegvisomant[1] D05394 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[2] 78, 265
260PEGylated Intereron Beta-1a----[1] 13
261Pegylated interferon alfa[1] Interferon alfa[1] D03305 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 96
262Pegylated Interferon Alpha2b----[1] 227
263PEGylated Interferon Beta-1a[2] Human interferon beta,
Interferon beta-1a		[1] D04554 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
264Pegylated polypeptide hormone of human recombinant origin PEG-hGH----[1] 78
265Pegylated recombinant human growth hormone[1] Somatotropin---[1] 78
266PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20[2] Hyaluronidase,
Hyaluronidase (human recombinant)		[3] D04455 ,
D04456 ,
D06604 		--[1] 28
267Pegylated Somatropin[1] Somatotropin---[1] 78
268Pelubiprofen[1] Pelubiprofen[1] D01865 --[1] 46
269Pelubiprofen 30 mg[1] Pelubiprofen[1] D01865 --[1] 46
270Pemafibrate[1] Pemafibrate[1] D10711 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
271Pembrolizumab[1] Pembrolizumab[1] D10574 [1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[2] 25, 285
272PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----[1] 171
273PEMIROLAST[1] Pemirolast[1] D07476 --[1] 113
274Pemziviptadil (PB1046) Injection----[1] 86
275PEN+usual care----[1] 96
276Pending----[6] 13, 19, 96, 97, 113, 302
277Penicillamine[1] Penicillamine[1] D00496 --[2] 51, 171
278Pentamidina[1] Pentamidine[1] D08333 --[1] 61
279PENTAMIDINA ISETIONATO[1] Pentamidine[1] D08333 --[1] 61
280Pentamidine[1] Pentamidine[1] D08333 --[2] 61, 65
281Pentasa[1] Mesalazine[1] D00377 --[2] 96, 97
282Pentasa 2g sachet prolonged release granules (95%)[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
283Pentasa 500 mg Retardtabletten[1] Mesalazine[1] D00377 --[1] 97
284Pentasa Compact 2g, granulate with prolonged release[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
285Pentasa Compact 4g, granulate with prolonged release[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
286Pentasa enema[1] Mesalazine[1] D00377 --[1] 97
287Pentasa prolonged release granules 2g[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 97
288PENTASA Sachet[1] Mesalazine[1] D00377 --[2] 96, 97
289Pentasa Sachet 1 g[1] Mesalazine[1] D00377 --[2] 96, 97
290Pentasa Sachet 1 g prolonged release granules[2] Manganese citrate,
Mesalazine		[1] D00377 --[1] 96
291Pentasa Sachet 1g[1] Mesalazine[1] D00377 --[1] 97
292Pentasa Sachet 2 g[1] Mesalazine[1] D00377 --[1] 97
293Pentetreotide[1] Pentetreotide[1] D01859 --[1] 75
294Pentosan Polysulfat SP 54® injection solution----[1] 19
295Pentosan polysulfate[1] Pentosan polysulfate---[3] 19, 26, 226
296PENTOSAN POLYSULFATE SODIUM[1] Pentosan polysulfate---[1] 19
297Pentosan polysulfate sodium 100 mg[1] Pentosan polysulfate---[1] 226
298Pentosan Polysulphate SP54----[1] 19
299Pentosan Polysulphate SP54®----[1] 19
300Pentoxifylline[1] Pentoxifylline[1] D00501 --[12] 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
301Pentoxifylline 400 MG[1] Pentoxifylline[1] D00501 --[1] 97
302Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----[1] 113
303Peptidic+Probiotic----[1] 96
304Perampanel[1] Perampanel[1] D08964 [4] GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		[16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[3] 2, 6, 144
305Percutaneous sirolimus[1] Sirolimus[1] D00753 [1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 278
306Perdix----[1] 19
307Peresolimab----[1] 46
308PERFALGAN----[1] 2
309Perflubutane[1] Perflubutane[1] D05440 --[2] 298, 300
310Perfluorinated gas/oxygen mixture[1] Oxygen[1] D00003 --[1] 299
311Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----[1] 265
312Perfusion of treatment Ocrelizumab[1] Ocrelizumab[1] D05218 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
313Perfusion of treatment Rituximab[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
314PERGOLIDE[1] Pergolide[1] D08339 [2] DRD1,
DRD2 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
315Perhexiline[1] Perhexiline[1] D08340 [8] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬		[47] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 58, 272
316Peri-neural Dexamethasone 1 mg[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
317Perindopril[1] Perindopril[1] D03753 [1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[4] 58, 113, 167, 222
318Perindopril 2mg Tablets[1] Perindopril[1] D03753 [1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 113
319PERINDOPRIL ARGININA[2] Arginine,
Perindopril		[2] D02982 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 58
320Perindopril arginine[2] Arginine,
Perindopril		[2] D02982 ,
D03753 		[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 58
321Peripheral blood stem cell----[1] 285
322Peripheral Blood Stem Cells----[2] 51, 65
323Permitted DMARDs----[1] 46
324Persantin----[1] 46
325Persantin 100 mg----[1] 46
326Persantin 100 mg and----[1] 46
327Personalized extended interval dosing of natalizumab[1] Natalizumab[1] D06886 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
328Pertactin[1] Bordetella pertussis pertactin antigen---[1] 46
329Pertactin adsorbed[1] Bordetella pertussis pertactin antigen---[1] 46
330PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated),
Hydroxide ion		[1] D02416 --[1] 46
331PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis pertactin antigen,
Hydroxide ion		[1] D02416 --[1] 46
332Pertussis toxoid[1] Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)---[1] 46
333PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide,
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated),
Hydroxide ion		[1] D02416 --[1] 46
334Pertussis vaccine[1] Pertussis vaccine[1] D06514 --[2] 13, 46
335PERTZYE----[1] 299
336Perxexiline----[1] 58
337PET----[1] 6
338PET with 11C-Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13
339PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----[1] 85
340PET10----[1] 41
341PET3----[1] 41
342Petrolatum[1] Petrolatum[1] D05331 --[1] 158
343Pexsig----[1] 58
344PF 06687234----[2] 96, 97
345PF-00489791[1] PF-00489791---[1] 86
346PF-00547659----[2] 96, 97
347PF-00547659 SC injection----[2] 96, 97
348PF-02545920----[1] 8
349PF-04171327----[1] 46
350PF-04171327 10 mg----[1] 46
351PF-04171327 25 mg----[1] 46
352PF-04236921----[2] 49, 96
353PF-04236921 SC injection----[1] 96
354PF-04383119----[1] 226
355PF-05208763----[1] 67
356PF-05230917----[1] 97
357PF-05280586----[1] 46
358PF-05285401----[1] 97
359PF-06252616[1] Domagrozumab[1] D11047 [1] MSTN 💬[1] Cytokine-cytokine receptor interaction 💬[1] 113
360PF-06291826-83/Fx-1006A[1] Fx-1006A---[1] 28
361PF-06342674 0.25 mg/kg----[1] 13
362PF-06342674 1.5 mg/kg----[1] 13
363PF-06342674 6.0 mg/kg----[1] 13
364PF-06410293----[1] 46
365PF-06412562----[1] 6
366PF-06438179----[1] 46
367PF-06462700----[1] 60
368PF-06480605----[1] 97
369PF-06480605 100 mg/ml----[1] 97
370PF-06649751[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
371PF-06649751 - 15mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
372PF-06649751 - 1mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
373PF-06649751 - 5mg[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
374PF-06649751 high dose (15 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
375PF-06649751 low dose (1 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
376PF-06649751 middle dose 1 (3 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
377PF-06649751 middle dose 2 (7 mg QD)[1] Tavapadon[1] D11431 [2] DRD1,
DRD5 💬		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6
378PF-06650833[1] PF-06650833---[1] 46
379PF-06650833 100 mg[1] PF-06650833---[1] 46
380PF-06650833 20 mg[1] PF-06650833---[1] 46
381PF-06651600[1] PF-06651600---[3] 46, 96, 97
382PF-06651600 10 mg[1] PF-06651600---[1] 97
383PF-06651600 50 mg[1] PF-06651600---[2] 96, 97
384PF-06651600 50mg[1] PF-06651600---[1] 96
385PF-06651600-15[1] PF-06651600---[2] 96, 97
386PF-06669571----[1] 6
387PF-06687234----[1] 97
388PF-06700841[1] PF-06700841---[3] 49, 96, 97
389PF-06700841 15 mg[1] PF-06700841---[1] 49
390PF-06700841 25 mg[1] PF-06700841---[2] 96, 97
391PF-06700841 25mg[1] PF-06700841---[1] 49
392PF-06700841 30 mg[1] PF-06700841---[1] 49
393PF-06700841 45 mg[1] PF-06700841---[1] 49
394PF-06700841 5 mg[1] PF-06700841---[3] 49, 96, 97
395PF-06700841 5mg[1] PF-06700841---[1] 49
396PF-06700841-15[1] PF-06700841---[3] 49, 96, 97
397PF-06730512----[1] 222
398PF-06755347 intravenous healthy participant----[1] 63
399PF-06755347 subcutaneous healthy participant----[1] 63
400PF-06755347 subcutaneous ITP----[1] 63
401PF-06823859----[1] 50
402PF-06823859 high----[1] 50
403PF-06823859 low----[1] 50
404PF-06826647----[1] 97
405PF-06826647 100 mg QD----[1] 97
406PF-06826647 300 mg QD----[1] 97
407PF-06826647 600 mg QD----[1] 97
408PF-06835375----[3] 46, 49, 63
409PF-06836922----[1] 78
410PF-06939926----[1] 113
411PF-07054894----[1] 97
412PF-07256472----[1] 276
413PF-6826647 400 mg QD----[1] 97
414PFD----[3] 51, 117, 298
415Pfefferminzblätter 1ml/10ml----[1] 97
416PFP----[1] 299
417PG----[1] 46
418PG-760564----[1] 46
419PG2----[1] 63
420PG203----[1] 6
421PGM169/GL67A----[1] 299
422PGT-1 gene lipid complex----[1] 299
423PGx-guided post-operative pain management----[2] 96, 97
424PH-797804[1] PH-797804---[1] 46
425Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid[1] Propanoic acid---[1] 6
426Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----[1] 6
427PHA-022121----[1] 65
428PHA-022121 high dose----[1] 65
429PHA-022121 low dose----[1] 65
430PHA-022121 medium dose----[1] 65
431PHA-022121 selected dose----[1] 65
432PHA-794,428----[1] 78
433PHA-794428----[1] 78
434Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----[1] 65
435Pharmacodynamics----[1] 34
436Pharmacokinetics of certolizumab pegol[1] Certolizumab pegol[1] D03441 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 96
437Pharmacokinetics study----[1] 50
438Pharmacologic approaches to glycemic treatment----[1] 298
439Phase 1, SQY51----[1] 113
440Phase 1: Conventiaonal DMARD----[1] 46
441Phase 1: Etanercept[1] Etanercept[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
442Phase 1: Methotrexate[1] Methotrexate[1] D00142 [2] DHFR,
DHFR2 💬		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46
443Phase 2----[1] 13
444Phase 2: Optional ETN, SSZ, HCQ, MTX----[1] 46
445Phase 2a, SQY51 (cohort 1)----[1] 113
446Phase 2a, SQY51 (cohort 2)----[1] 113
447Phase 2a, SQY51 (cohort 3)----[1] 113
448Phase 3----[1] 13
449Phase1 : CDED/Modulen™IBD® + Maintenance therapy----[1] 96
450Phase2 and 3 :----[1] 96
451Phe----[1] 75
452Pheburane[1] Phenylbutyric acid---[1] 21
453Phenlarmide Tablets----[1] 6
454Phenoptin----[2] 124, 240
455Phenothiazine[1] Phenothiazine[1] D02601 --[1] 127
456Phentermine[1] Phentermine[1] D05458 [5] MAOA,
MAOB,
SLC6A2,
SLC6A3,
SLC6A4 💬		[16] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬[1] 97
457Phentermine-Topiramate[2] Phentermine,
Topiramate		[2] D00537 ,
D05458 		[41] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
MAOA,
MAOB,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SLC6A2,
SLC6A3,
SLC6A4 💬		[63] Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 97
458Phenylalanine[1] Phenylalanine[1] D00021 --[1] 240
459Phenylalanine restricted diet[1] Phenylalanine[1] D00021 --[1] 240
460Phenylalanine-free protein substitute in tablet form (XPhe minis)[1] Phenylalanine[1] D00021 --[1] 240
461Phenylalanine-free protein substitute tablets[1] Phenylalanine[1] D00021 --[1] 240
462PHENYLBUTYRATE[1] Phenylbutyric acid---[12] 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
463Phenylbutyrate Oral Tablet[1] Phenylbutyric acid---[1] 15
464PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR[1] Lysine[1] D02304 --[1] 13
465Phenylephrine[1] Phenylephrine[1] D08365 [3] ADRA1A,
ADRA1B,
ADRA1D 💬		[7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 22
466Phenylketonuria-type diet----[1] 240
467Phenytoin[1] Phenytoin[1] D00512 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 13
468Pheripheral blood stem cells----[1] 65
469PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid[1] Propanoic acid---[1] 6
470PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----[1] 6
471Phosphate[1] Phosphate ion---[32] 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
472Phosphate and betamethasone acetate, 2 mL.[3] Acetate,
Betamethasone,
Phosphate ion		[1] D00244 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 235
473Phosphate sandoz[1] Phosphate ion---[1] 78
474Phosphate tablets.[1] Phosphate ion---[1] 238
475Phosphate-buffered saline[1] Phosphate ion---[1] 49
476Phosphate.[1] Phosphate ion---[1] 238
477Phosphatidylcholine[1] Lecithin[1] D04682 --[1] 97
478Phosphodiesterase Inhibitors----[1] 51
479Phospholipids[1] Omega-3 fatty acids---[1] 79
480Phosphorodiamidate Morpholino Oligomer----[1] 113
481Phosphorodiamidate morpholino oligomer for exon 45 skipping----[1] 113
482Phosphorodiamidate morpholino oligomer for exon 53 skipping----[1] 113
483Phosphorus[1] Phosphorus---[1] 238
484Photodynamic therapy with Gliolan[1] Aminolevulinic acid[1] D07567 --[1] 97
485PHP-303----[1] 231
486PHVS416----[1] 65
487Phylloquinone[1] Phylloquinone---[1] 96
488Phylloquinone (vitamin K1)[1] Phylloquinone---[1] 96
489Physician standard-of-care----[1] 96
490Physiologic serum nebulized nasally----[1] 299
491Physiological saline----[1] 51
492Physiological serum (Sodium chloride)[2] Chloride ion,
Sodium chloride		[1] D02056 --[1] 193
493Physiological solution----[1] 299
494PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung----[1] 227
495Physiologische Kochsalzlösung Fresenius - Infusionslösung----[1] 288
496Phytomenadione[1] Phylloquinone---[1] 288
497PI-0824[1] PI-0824---[1] 35
498PI-2301----[1] 13
499Picibanil----[1] 278
500Piclidenoson[1] Piclidenoson[1] D10971 [1] ADORA3 💬[3] Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
501Piclozotan[1] Piclozotan---[1] 6
502Picoprep----[1] 98
503Picosulfate[1] Picosulfuric acid---[2] 97, 291
504PID----[1] 65
505Pig whipworm eggs----[1] 46
506Pilocarpine[1] Pilocarpine[1] D00525 [2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[3] 6, 53, 299
507Pilocarpine Hydrochloride[1] Pilocarpine[1] D00525 [2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 53
508Pilocarpine Nitrate 5%[2] Nitrate,
Pilocarpine		[2] D00525 ,
D02313 		[2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 299
509Pimavanserin[1] Pimavanserin---[1] 6
510Pimavanserin (ACP-103)[1] Pimavanserin---[1] 6
511Pimavanserin tartrate[1] Pimavanserin---[1] 6
512Pimavanserin tartrate (ACP-103)[1] Pimavanserin---[1] 6
513Pimecrolimus[1] Pimecrolimus[1] D05480 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 160
514Pimecrolimus 1% Cream[1] Pimecrolimus[1] D05480 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 160
515Pimozide[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
516Pimozide 2 mg per day[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
517Pimozide 2mg/day (current) or 4 mg/day (study initiation)[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
518Pimozide 4 mg per day[1] Pimozide[1] D00560 [2] ADRA2A,
DRD2 💬		[9] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
519Pioglitazone[1] Pioglitazone[1] D08378 [1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
520Pioglitazone 15 mg[1] Pioglitazone[1] D08378 [1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 96
521Pioglitazone and Tretinoin[2] Pioglitazone,
Tretinoin		[2] D00094 ,
D08378 		[4] PML,
PPARG,
RARA,
RARB 💬		[21] AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 2
522Pioglitazone or metformin[2] Metformin,
Pioglitazone		[2] D04966 ,
D08378 		[3] PPARG,
PRKAA1,
PRKAA2 💬		[27] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬[1] 265
523PIPE-307----[1] 13
524PIPERACILLIN[1] Piperacillin[2] D02251 ,
D08380 		--[1] 299
525PIPERACILLIN SODIUM[1] Piperacillin[2] D02251 ,
D08380 		--[1] 299
526Piperacillin sodium , tazobactam sodium[2] Piperacillin,
Tazobactam		[3] D00660 ,
D02251 ,
D08380 		--[1] 299
527Piperacillin with Tazobactam (tazocin)[2] Piperacillin,
Tazobactam		[3] D00660 ,
D02251 ,
D08380 		--[1] 299
528Piperacillin-tazobactam combination product[2] Piperacillin,
Tazobactam		[3] D00660 ,
D02251 ,
D08380 		--[1] 299
529Piperacillin/Tazobactam[2] Piperacillin,
Tazobactam		[3] D00660 ,
D02251 ,
D08380 		--[1] 299
530Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria[2] Piperacillin,
Tazobactam		[3] D00660 ,
D02251 ,
D08380 		--[1] 299
531Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie[1] Tazobactam[1] D00660 --[1] 299
532Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie[1] Tazobactam[1] D00660 --[1] 299
533Piperazine[1] Piperazine[1] D00807 --[2] 58, 272
534PIR, S-7701----[1] 85
535Pirepemat----[1] 6
536Pirepemat x fumarate----[1] 6
537Pirepemat, 100 mg----[1] 6
538Pirepemat, 50 mg----[1] 6
539Pirfenidone[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
540Pirfenidone (PFD)[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
541Pirfenidone 267 MG [Esbriet][1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 228
542Pirfenidone and nintedanib[2] Nintedanib,
Pirfenidone		[2] D01583 ,
D10481 		[14] CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		[106] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
543Pirfenidone or nintedanib[2] Nintedanib,
Pirfenidone		[2] D01583 ,
D10481 		[14] CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		[106] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
544Pirfenidone Solution for Inhalation[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
545Pirfenidone, deuterated[1] Pirfenidone[1] D01583 [6] CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		[84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
546Pirfenidoneone----[1] 85
547Piribedil[1] Piribedil[1] D07305 [2] DRD2,
DRD3 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
548Piribedil (Clarium)[1] Piribedil[1] D07305 [2] DRD2,
DRD3 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
549Pitavastatin[1] Pitavastatin---[1] 49
550Pitolisant[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 113, 193
551Pitolisant Oral Tablet[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
552Pitolisant oral tablets[1] Pitolisant[1] D10749 [1] HRH3 💬[1] Neuroactive ligand-receptor interaction 💬[1] 193
553Pittsburgh Compound B[1] Pittsburgh Compound B---[1] 127
554Pittsburgh Compound B (C-11 PiB)[1] Pittsburgh Compound B---[1] 127
555PIXANTRONE[1] Pixantrone[1] D05522 [2] TOP2A,
TOP2B 💬		[1] Platinum drug resistance 💬[2] 11, 13
556PK-Merz----[1] 6
557PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj[1] Amantadine[1] D07441 [5] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6
558PKD Patients----[1] 6
559PKU Explore----[1] 240
560PKU express plus----[1] 240
561PKU Sphere----[1] 240
562PKU sphere liquid----[1] 240
563PKU Start----[1] 240
564PKU/TYR GMP Protein Substitute----[1] 240
565PL 00095/5079R----[1] 46
566PL 0010/0211----[1] 299
567PL 00512/0150----[1] 298
568PL 04515/0127----[1] 13
569PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)[1] Water[1] D00001 --[1] 57
570PL 12762/0049----[1] 13
571PL 17901/0122----[1] 96
572PL 20532/0012----[1] 96
573PL101----[1] 8
574PL8177----[1] 97
575PLA + MTX switched to ABA+ MTX, DB----[1] 46
576PLA-695----[1] 46
577PLA-PRU-PLA-PRU----[1] 99
578PLA-PRU-PRU-PLA----[1] 99
579Placebo----[28] 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
580Placebo (physiological saline)----[2] 43, 45
581Placebo IV----[1] 50
582Placebo SC----[1] 50
583Placental Mesenchymal Stem Cells[1] Placental Mesenchymal Stem Cells---[1] 118
584Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix[1] Placental Mesenchymal Stem Cells---[1] 118
585PLACENTEX ® Polydeoxyribonucleotide----[1] 51
586PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml----[1] 51
587PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿----[1] 51
588Plaebo----[1] 46
589Plant cell expressed recombinant glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
590Plant Cell Recombinant Glucocerebrosidase----[1] 19
591Plantago ovata husk----[1] 6
592Plantain NSP----[1] 96
593Plaquenil----[4] 46, 49, 53, 96
594Plaquenil - Hydroxychloroquine 200mg Film coated tablets[1] Hydroxychloroquine[1] D08050 --[3] 43, 44, 45
595Plaquenil 200 mg filmdrasjerte tabletter----[1] 46
596PLAQUENIL*25CPR RIV 200MG[1] Hydroxychloroquine[1] D08050 --[1] 84
597Plasma analysis for bacterial translocation----[1] 46
598Plasma exchange (PE)----[1] 64
599Plasma from healthy young people treatment + Riluzole[1] Riluzole[1] D00775 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		[23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2
600Plasma Lyso-GB3----[1] 19
601Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----[1] 96
602Plasma-derived FVIII/VWF concentrate----[1] 288
603PLASMASAFE----[1] 274
604PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----[1] 274
605Platelet enriched plasma----[1] 226
606Platelet Gel----[1] 51
607Platelet Rich Plasma----[2] 46, 90
608Platelet transfusion----[1] 13
609Platelet-Rich Plasma----[1] 226
610Platform----[1] 13
611Plecebo----[1] 256
612PLECONARIL[1] Pleconaril[1] D05528 --[1] 2
613PLEDIGRY----[1] 13
614Plegridy[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
615Plegridy (peginterferon beta-1a), Biogen Idec Ltd[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
616PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
617Plegridy 125 micrograms[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
618Plegridy 63 micrograms[1] Peginterferon beta-1a[1] D10483 [2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
619Plenadren 20 mg modified-release tablets[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 78
620Plenadren 5 mg modified-release tablets[2] Hydrocortisone,
Manganese citrate		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 78
621Pleneva TM BGC20-0134----[1] 13
622PLENUR----[1] 2
623PLERIXAFOR[1] Plerixafor[1] D08971 [1] CXCR4 💬[14] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬[4] 20, 65, 285, 299
624Plerixafor for Conditioning before HSCT.[1] Plerixafor[1] D08971 [1] CXCR4 💬[14] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬[1] 65
625Plerixafor mobilization of autologous CD117 stem cells[1] Plerixafor[1] D08971 [1] CXCR4 💬[14] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬[1] 299
626PLETAL[1] Cilostazol[1] D01896 [3] PDE3A,
PDE3B,
TBXA2R 💬		[14] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 51
627PLF with NeoFuse----[1] 70
628PLN-74809[1] PLN-74809---[2] 85, 94
629PLN-74809-000[1] PLN-74809---[1] 85
630PLN-74809-020[1] PLN-74809---[1] 85
631Plovamer acetate[1] Acetate---[1] 13
632Plovamer acetate 0.5 milligram (mg)[1] Acetate---[1] 13
633Plovamer acetate 10 mg[1] Acetate---[1] 13
634Plovamer acetate 20 mg[1] Acetate---[1] 13
635Plovamer acetate 3 mg[1] Acetate---[1] 13
636PLP----[1] 13
637PLP peptide----[1] 13
638PLX-200----[1] 19
639PLX-PAD[1] Placental Mesenchymal Stem Cells---[1] 86
640PLX3397----[1] 46
641PLX5622----[1] 46
642Plérixafor----[1] 285
643PMG1015 Dose 1----[1] 85
644PMG1015 Dose 2----[1] 85
645PMG1015 Dose 3----[1] 85
646PMG1015 Dose 4----[1] 85
647PMG1015 Dose 5----[1] 85
648PMG1015 Dose 6----[1] 85
649PMG1015 Dose 7----[1] 85
650PN 200 tablets (500 mg naproxen and 20 mg omeprazole)[2] Naproxen,
Omeprazole		[2] D00118 ,
D00455 		[4] ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		[26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
651PN-101----[1] 50
652PN-10884A----[1] 97
653PN-180307----[1] 78
654PN-943----[1] 97
655PnCJ PPS----[1] 65
656Pnemovax----[1] 96
657PNEUMO 23----[1] 65
658Pneumo23----[1] 107
659Pneumo23 / Pneumovax----[1] 46
660Pneumococcal conjugate vaccine----[1] 46
661PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----[2] 13, 14
662PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE[4] Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein,
Phosphate ion		---[1] 46
663Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----[1] 46
664Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----[1] 46
665Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----[1] 222
666Pneumococcal polysaccharide serotype 11 2.2 µg----[1] 222
667Pneumococcal polysaccharide vaccine----[3] 13, 46, 222
668PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)----[1] 46
669Pneumococcal polysaccharide vaccine 23 valent----[1] 265
670Pneumococcal polysaccharide vaccine solution for injection in a vial----[1] 222
671Pneumococcal serotypes----[1] 46
672Pneumovax----[3] 46, 49, 96
673Pneumovax 23[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[2] 46, 50
674Pneumovax II----[1] 13
675PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----[2] 62, 66
676Pneumovax® (pneumococcal polysaccharide vaccine)----[1] 65
677PNEUMOVAX® 23----[1] 46
678PNU-215062 sodium salt----[1] 13
679PO----[1] 13
680PO azithromycin[1] Azithromycin[2] D06390 ,
D07486 		--[1] 299
681PO ciprofloxacin[1] Ciprofloxacin[1] D00186 --[1] 299
682POL6014----[1] 299
683POL7080----[1] 299
684Polaprezinc[1] Polaprezinc[1] D01611 --[2] 96, 97
685Polidocanol[1] Polidocanol[1] D01993 --[1] 279
686Poly ICLC----[1] 34
687POLY(OXY-1,2-ETHANEDIYL), A----[1] 235
688POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[1] Diethyl ether[1] D01772 --[1] 235
689POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI[1] Diethyl ether[1] D01772 --[1] 235
690POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)[2] Diethyl ether,
Teriparatide		[2] D01772 ,
D06078 		[1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
691Polyclonal IgG----[1] 65
692POLYDEOXYRIBONUCLEOTIDES----[2] 51, 70
693Polyethylene glycol[1] Polyethylene glycol[1] D03370 --[7] 6, 78, 96, 97, 235, 276, 299
694Polyethylene Glycol 3350[1] Polyethylene glycol[1] D03370 --[2] 96, 299
695Polymerase chain reaction----[2] 65, 285
696Polymorphism Analysis----[2] 49, 60
697Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----[1] 13
698PolyMVA----[1] 2
699Polyphenon E----[2] 13, 36
700Polyphenon E®----[1] 97
701Pomalidomida[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
702Pomalidomide[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[5] 28, 51, 85, 227, 331
703Pomalidomide (CC-4047[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 85
704Pomalidomide (CC-4047)[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 51
705Pomalidomide and Dexamethasone[2] Dexamethasone,
Pomalidomide		[2] D00292 ,
D08976 		[3] IL6,
NR3C1,
TNF 💬		[81] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
706Pomalidomide Oral Product[1] Pomalidomide[1] D08976 [2] IL6,
TNF 💬		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 227
707PONESIMOD[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
708Ponesimod 10 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
709Ponesimod 20 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
710Ponesimod 40 mg[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
711Ponticelli Regimen----[1] 222
712Ponvory[1] Ponesimod[1] D11215 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
713Pooled mesenchymal stem cell----[1] 49
714Pooled Plasma (Human), Solvent/Detergent Treated----[1] 64
715Porcine (pig) PERT----[1] 299
716Porcine PERT----[1] 299
717Porphobilinogen[1] Porphobilinogen---[1] 254
718Posaconazole[1] Posaconazole[1] D02555 --[3] 60, 65, 299
719Posaconazole (PSZ)[1] Posaconazole[1] D02555 --[1] 65
720Posaconazole 100 MG [Noxafil][1] Posaconazole[1] D02555 --[1] 299
721Posaconazole 40 MG/ML[1] Posaconazole[1] D02555 --[1] 299
722POSACONAZOLO----[1] 299
723Posiphen[1] Posiphen---[1] 6
724Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)[1] Activated charcoal---[1] 6
725Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----[1] 6
726Post-CPB Drug: Dobutamine Hydrochloride[1] Dobutamine[1] D03879 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58
727Postoperative 3-month exclusive enteral nutrition----[1] 96
728Potassium[1] Potassium[1] D08403 --[13] 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235
729Potassium sparing diuretic[1] Potassium[1] D08403 --[1] 235
730Potassium supplement[1] Potassium[1] D08403 --[1] 46
731Potiga[1] Ezogabine[1] D09569 [5] KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬		[6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬[1] 144
732Povetacicept----[3] 61, 63, 222
733Powder for Oral Suspension)----[1] 113
734Pozelimab[1] Pozelimab[1] D11477 [1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[2] 11, 62
735Pozelimab + Cemdisiran[2] Cemdisiran,
Pozelimab		[1] D11477 [1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 11
736PPI treatment----[1] 299
737PPS----[1] 65
738Pr----[1] 41
739PR Oxycodone[1] Oxycodone[1] D05312 [3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
740PR-06410293----[1] 46
741PR1----[1] 51
742PRA023----[3] 51, 96, 97
743PRA023 IV----[3] 51, 96, 97
744PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
745PRALIA 60mg Subcutaneous Injection Syringe(denosumab)[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
746Praluent[1] Alirocumab[1] D10335 [1] PCSK9 💬[1] Cholesterol metabolism 💬[1] 79
747Pramipexol[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
748Pramipexol Extended Release[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
749Pramipexol Immediate Release[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
750Pramipexole[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 2, 6, 20
751Pramipexole 0.125 mg tablets[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
752Pramipexole 0.5 mg tablets[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
753PRAMIPEXOLE DIHYDROCHLORIDE[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
754Pramipexole dihydrochloride extended-release tablets[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
755PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
756Pramipexole dihydrochloride monohydrate extended release[2] Manganese citrate,
Pramipexole		[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
757Pramipexole ER[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
758Pramipexole Extended Release[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
759Pramipexole extended release tablet[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
760Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
761Pramipexole Immediate Release[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
762Pramipexole immediate release tablet[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
763Pramipexole IR[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
764Pramipexole or ropinirole[2] Pramipexole,
Ropinirole		[2] D05575 ,
D08489 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
765Pramipexole SR[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
766Prasinezumab[1] Prasinezumab[1] D11420 [1] SNCA 💬[3] Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 6
767Prasterone[1] Prasterone[1] D08409 [3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
768Prasterone (GL701)[1] Prasterone[1] D08409 [3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
769Pravastatin[1] Pravastatin[1] D08410 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[9] 13, 46, 49, 67, 79, 96, 164, 265, 333
770Pravastatin sodium[1] Pravastatin[1] D08410 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 265
771Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)[1] Pramipexole[1] D05575 [3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
772PRD2175434----[1] 113
773PRD4862257----[1] 46
774PRD5973697----[1] 97
775PRD7255830----[1] 79
776PRD7255977----[1] 79
777PRD7256003----[1] 79
778PRD806998----[1] 13
779Pre and post-CPB Drug: Dobutamine Hydrochloride[1] Dobutamine[1] D03879 [1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58
780Pre-filled syringe----[1] 46
781Prebiotics----[2] 96, 97
782Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----[1] 13
783Precedentemente denominato MEDI2070 e AMG 139----[1] 96
784Precision dosing with a dashboard----[1] 96
785Pred----[1] 46
786Pred + Meth----[1] 46
787Predinose oral----[1] 70
788PredniHEXAL----[1] 46
789PredniHEXAL® 10mg Tabletten----[1] 46
790PredniHEXAL® 20mg Tabletten----[1] 46
791PredniHEXAL® 5mg Tabletten----[1] 46
792PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten----[1] 46
793PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten----[1] 46
794Predniso----[1] 46
795Prednisolene tablets BP 1 mg----[1] 46
796Prednisolon----[7] 46, 50, 51, 66, 95, 96, 97
797Prednisolon 1 mg JENAPHARM----[1] 41
798Prednisolon 10 mg JENAPHARM----[1] 41
799Prednisolon 20 mg JENAPHARM----[1] 41
800Prednisolon 5 mg JENAPHARM----[1] 41
801Prednisolon Jenapharm----[2] 96, 97
802Prednisolon Pfizer----[2] 46, 50
803Prednisolona[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
804PREDNISOLONE[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[42] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
805Prednisolone & dipyridamole[2] Dipyridamole,
Prednisolone		[2] D00302 ,
D00472 		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
806Prednisolone + mabthera[2] Prednisolone,
Rituximab		[2] D00472 ,
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
807Prednisolone 1mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
808Prednisolone 2,5 mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
809Prednisolone 20 mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
810Prednisolone 40 mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
811Prednisolone 5 mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 51
812Prednisolone 5 mg JENAPHARM[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
813Prednisolone 5 mg Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
814Prednisolone 5mg Gastro-resistant Tablets[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
815Prednisolone 5mg Tablet[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
816PREDNISOLONE ACETATE[3] Acetate,
Prednisolone,
Prednisolone acetate		[2] D00472 ,
D00980 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
817Prednisolone and chlorambucil[2] Chlorambucil,
Prednisolone		[2] D00266 ,
D00472 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
818Prednisolone and mycophenolate mofetil[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		[3] D00472 ,
D00752 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 222
819Prednisolone and taper[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
820Prednisolone Labesfal[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
821Prednisolone sodium metasulphobenzoate[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
822PREDNISOLONE SODIUM PHOSPHATE[2] Phosphate ion,
Prednisolone		[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97
823PREDNISOLONE SODIUM SUCCINATE[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 95
824Prednisolone Tablets B.P. 5mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
825Prednisolone Tablets BP[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
826Prednisolone Tablets BP 1 mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
827Prednisolone Tablets USP 5 mg[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
828Prednisolone-Dipyridamole[2] Dipyridamole,
Prednisolone		[2] D00302 ,
D00472 		[3] NR3C1,
PDE4A,
PDE5A 💬		[7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
829Prednisolone/Prednisone[2] Prednisolone,
Prednisone		[2] D00472 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
830Prednisoloni----[1] 51
831Prednisolonum[1] Prednisolone[1] D00472 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 51
832Prednison----[3] 46, 84, 113
833Prednison 10 mg GALEN----[1] 35
834Prednison 5 mg GALEN----[1] 35
835PREDNISON 5, 20 Léciva por. tablet nob----[1] 50
836Prednison 5, 20 Léciva por. tablet nob.----[1] 50
837Prednison 50 mg GALEN----[1] 35
838Prednison acis® 20 mg----[2] 43, 44
839Prednison acis® 5 mg----[2] 43, 44
840Prednison acis¿ 20 mg----[2] 43, 44
841Prednison acis¿ 5 mg----[2] 43, 44
842Prednison20 mg GALEN----[1] 35
843Prednisona[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 46, 49, 222
844Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
845Prednisone (and methylprednisolone)[2] Methylprednisolone,
Prednisone		[2] D00407 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43
846Prednisone + Inhibace/Cozaar[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
847Prednisone - Azathioprine[2] Azathioprine,
Prednisone		[2] D00238 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 11
848Prednisone 0,5 mg/kg orally on alternate days[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
849Prednisone 1 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
850Prednisone 15 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
851Prednisone 2 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
852Prednisone 3 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
853Prednisone 4 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
854Prednisone 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 66
855Prednisone 5 mg tablets[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
856Prednisone 7.5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
857Prednisone acetate[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 ,
D08416 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 46, 49, 224
858Prednisone Acetate Tablets[3] Acetate,
Prednisone,
Prednisone acetate		[2] D00473 ,
D08416 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 224
859Prednisone alone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 11, 66
860Prednisone and Belimumab[2] Belimumab,
Prednisone		[2] D00473 ,
D03068 		[2] NR3C1,
TNFSF13B 💬		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300
861Prednisone and cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
862Prednisone and Mycophenolate mofetil[3] Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[3] D00473 ,
D00752 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 300
863Prednisone and ustekinumab treatment[2] Prednisone,
Ustekinumab		[2] D00473 ,
D09214 		[4] IL12A,
IL12B,
IL23A,
NR3C1 💬		[29] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 41
864PREDNISONE ARROW 20mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
865PREDNISONE ARROW 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
866Prednisone Capsule[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
867Prednisone Capsules[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
868Prednisone discontinuation[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 49
869PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 19
870PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 300
871Prednisone in full dose[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
872Prednisone or Prednisolone[2] Prednisolone,
Prednisone		[2] D00472 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 84
873Prednisone plus cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
874Prednisone plus exercise[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113
875PredniSONE Tablets USP, 1 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
876PredniSONE Tablets USP, 10 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
877PredniSONE Tablets USP, 1mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
878PredniSONE Tablets USP, 2.5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
879PredniSONE Tablets USP, 2.5mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
880PredniSONE Tablets USP, 20mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
881PredniSONE Tablets USP, 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 41, 46
882PredniSONE Tablets USP, 5mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
883PredniSONE Tablets, USP[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 41, 43, 44
884PredniSONE Tablets, USP 10 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
885PredniSONE Tablets, USP 2.5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
886PredniSONE Tablets, USP 5 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
887PredniSONE Tablets, USP, 1 mg[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
888Prednisone therapy and pharmacokinetic[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
889Prednisone treatment[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
890Prednisone with daily edasalonexent[2] Edasalonexent,
Prednisone		[2] D00473 ,
D12181 		[2] NR3C1,
RELA 💬		[77] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬[1] 113
891Prednisone, ciclosporin and mycophenolate mofetil[4] Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[4] D00184 ,
D00473 ,
D00752 ,
D05096 		[8] IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[38] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222
892Prednisone, cyclophosphamide[2] Cyclophosphamide,
Prednisone		[3] D00287 ,
D00473 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 40
893Prednisone, FK506, MMF[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
894Prednisone, low dose rituximab[2] Prednisone,
Rituximab		[2] D00473 ,
D02994 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
895Prednisone, methylprednisolone,cyclophosphamides[2] Methylprednisolone,
Prednisone		[2] D00407 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
896Prednisone/Prednisolone[2] Prednisolone,
Prednisone		[2] D00472 ,
D00473 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35
897Prednizolon----[1] 51
898Prednizolonas----[1] 51
899Prefilled liquid etanercept(Yisaipu)[2] Etanercept,
Yisaipu		[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271
900Prefilled Syringe delivery of Golimumab[1] Golimumab[1] D04358 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97
901Prefolic----[1] 337
902PREFOLIC 15*30CPR GASTROR 15MG----[1] 337
903PREFOLIC*30CPR GASTROR 15MG----[1] 299
904Pregabalin[1] Pregabalin[1] D02716 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[5] 13, 36, 46, 70, 298
905Pregabalin 75mg[1] Pregabalin[1] D02716 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[1] 70
906Preimplantation factor[1] Preimplantation factor---[1] 95
907Preladenant[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
908Preladenant 10 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
909Preladenant 2 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
910Preladenant 5 mg tablet[1] Preladenant[1] D09717 [1] ADORA2A 💬[7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6
911Premarin and Provera----[1] 49
912Premarin ®----[1] 6
913PREOTACT[1] Parathyroid hormone[1] D05364 [2] PTH1R,
PTH2R 💬		[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
914Preparative regimen 4-6 weeks after Leukapheresis----[1] 96
915Prepulsid----[1] 13
916Prescribe N-acetylcysteine tablets[1] Acetylcysteine[1] D00221 --[1] 90
917Preservative free artificial tear gel.----[1] 157
918PREVENAR----[1] 65
919Prevenar 13[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[5] 13, 14, 46, 96, 222
920PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 222
921Prevenar 13 sospensione per iniezione[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 14
922Prevenar 13 suspension for injection[1] Streptococcus pneumoniae type 1 capsular polysaccharide antigen---[1] 222
923Prevenar vaccination----[1] 46
924Prevenar vaccine----[1] 46
925Prevenar13----[2] 19, 265
926Prevenar® (7-valent pneumococcal conjugate vaccine)----[1] 65
927Prevenar® and Pneumo23®----[1] 49
928Previously known as R935788----[1] 46
929Previously referred to as MEDI2070 and AMG 139----[2] 96, 97
930Previously referred to as MEDI2070 and AMG 139, AGN-151-598----[1] 96
931Previously termed sc.AAV9.CB.SMN and AVXS-101----[1] 3
932PrGCD[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
933Pridia (Donepezil Hydrochloride) 5mg[1] Donepezil[1] D07869 [1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 6
934Pridia 10mg----[1] 6
935Pridia 5mg----[1] 6
936Pridiopidine----[1] 8
937Pridopidina----[1] 8
938Pridopidine[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 2, 6, 8
939Pridopidine (90 mg)[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8
940PRIDOPIDINE HYDROCHLORIDE[1] Pridopidine[1] D09953 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 8
941PRIM-DJ2727----[2] 6, 97
942Primary Cervical Dystonia (Trihexyphenidyl)[1] Trihexyphenidyl[1] D08638 [5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6
943Primavanserin tartrate----[1] 6
944PrimeC----[1] 2
945Primidone[1] Primidone[1] D00474 --[1] 2
946Prior Donepezil 5mg[1] Donepezil[1] D07869 [1] ACHE 💬[2] Cholinergic synapse, Glycerophospholipid metabolism 💬[1] 6
947Prior Donzepezil 10mg----[1] 6
948PRIVIGEN[1] Human immunoglobulin G---[4] 11, 14, 51, 65
949PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML----[1] 51
950Privigen 100 mg/ml, solution pour perfusion----[1] 53
951PRIVIGEN 100mg/ml----[1] 85
952Privigen®[1] Human immunoglobulin G---[3] 14, 63, 65
953PRM-151[1] PRM-151---[1] 85
954PRM-151 (Zinpentraxin Alfa)[1] PRM-151---[1] 85
955PRN1008----[2] 35, 61
956PRN1008 (Rilzabrutinib)----[1] 35
957PRN1008 Freebase----[1] 35
958PRN2246----[2] 11, 13
959PRO044----[1] 113
960PRO044 IV----[1] 113
961PRO044 IV 6 mg/kg----[1] 113
962PRO044 IV 9 mg/kg----[1] 113
963PRO044 SC----[1] 113
964PRO044 SC 6 mg/kg----[1] 113
965PRO045[1] BMN-045---[1] 113
966PRO045, 0.15 mg/kg/week[1] BMN-045---[1] 113
967PRO045, 1.0 mg/kg/week[1] BMN-045---[1] 113
968PRO045, 3.0 mg/kg/week[1] BMN-045---[1] 113
969PRO045, 6.0 mg/kg/week[1] BMN-045---[1] 113
970PRO045, 9.0 mg/kg/week[1] BMN-045---[1] 113
971PRO045, selected dose[1] BMN-045---[1] 113
972PRO051----[1] 113
973PRO053----[1] 113
974PRO145223----[1] 97
975PRO145223 (RO5490261)----[1] 97
976PRO283698----[1] 46
977Probenecid[1] Probenecid[1] D00475 --[1] 25
978Probiotic----[8] 2, 6, 93, 96, 97, 193, 266, 299
979Probiotic - VSL#3----[1] 96
980Probiotic Capsule----[1] 6
981Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-14[1] Lactobacillus delbrueckii bulgaricus---[1] 46
982Probiotic Formula Capsule----[1] 97
983Probiotic group----[1] 271
984Probiotic Mixture----[2] 96, 97
985Probiotic Product - Cap----[1] 53
986Probiotic-Lactobacillus plantarum PS128[1] Lactobacillus plantarum---[1] 156
987Probiotics----[5] 6, 94, 96, 97, 291
988Probiotics (Visbiome®)----[1] 13
989Probiotics with prebiotic----[1] 6
990Probucol[1] Probucol[1] D00476 --[1] 66
991Procaptan----[1] 58
992PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP----[1] 58
993PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP----[1] 58
994Procarbazine[1] Procarbazine[1] D08423 --[1] 65
995Prochymal[1] Remestemcel-L[1] D09719 --[1] 96
996PROCHYMAL (remestemcel-L)[1] Remestemcel-L[1] D09719 --[1] 96
997PROCHYMAL adult human mesenchymal stem cells[1] Remestemcel-L[1] D09719 --[1] 96
998Prochymal®[1] Remestemcel-L[1] D09719 --[1] 96
999Prochymal™ adult human mesenchymal stem cells[1] Remestemcel-L[1] D09719 --[1] 96
1000PROCYSBI[1] Cysteamine[1] D03634 --[1] 19
1001Prodarsan----[1] 192
1002Products containing aminosalicylate----[1] 97
1003Products containing azathioprine or 6-mercaptopurine[2] Azathioprine,
Mercaptopurine		[3] D00161 ,
D00238 ,
D04931 		[1] HPRT1 💬[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 97
1004Profilassi per Herpes Zoster----[1] 107
1005Progerinin----[2] 191, 333
1006Progesterone[1] Progesterone[1] D00066 [1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[2] 76, 299
1007Proglumide[1] Proglumide[1] D01818 [1] CCKBR 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 298
1008Prograf[1] Tacrolimus[2] D00107 ,
D08556 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[3] 60, 222, 226
1009Prograft capsules----[1] 299
1010Progressive spacing of TNF-blocker injections----[1] 46
1011Progynova 21 mite----[1] 65
1012Prohance (Gadoteridol)[1] Gadoteridol[1] D01137 --[1] 13
1013Prolastin----[3] 231, 298, 299
1014Prolastin (drug)----[1] 299
1015Prolastin-C[1] Alpha-1-proteinase inhibitor---[2] 231, 298
1016Prolastin-C, 120 mg/kg[1] Alpha-1-proteinase inhibitor---[1] 231
1017Prolastin-C, 60 mg/kg[1] Alpha-1-proteinase inhibitor---[1] 231
1018Proleukin[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[3] 2, 49, 65
1019Proleukin 18 MUI[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 2
1020PROLEUKIN® S[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 65
1021Prolia[1] Denosumab[1] D03684 [1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274
1022Proline[1] Proline[1] D00035 --[2] 94, 97
1023Prolonged release tablet[1] Manganese citrate---[1] 6
1024Prolonged-release Fampridine[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
1025Prolopa®----[1] 6
1026Prolotherapy solution of 20% dextrose[1] Dextrose, unspecified form---[1] 70
1027Promacta[1] Eltrombopag---[2] 63, 65
1028Promethazine[1] Promethazine[1] D00494 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 96
1029Promethera HepaStem----[1] 251
1030Prometic's Immune Globulin Intravenous 10%----[1] 65
1031Promiten----[1] 97
1032Promixin----[1] 299
1033Promixin 1 million International Units (IU) Powder for Nebuliser Solution----[1] 299
1034PROMIXIN*NEBUL 30MONOD 1MUI----[1] 299
1035Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----[1] 299
1036Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----[1] 299
1037Promixin/Tadim----[1] 299
1038Propanoic acid[2] Naproxen,
Propanoic acid		[1] D00118 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 6, 271
1039Propanolol[1] Propranolol[1] D08443 [3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 296
1040Propantheline[1] Propantheline---[1] 26
1041Propantheline Bromide[1] Propantheline---[1] 26
1042Prophylactic Corticosteroid Taper Regimen----[1] 251
1043Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----[1] 13
1044PROPIONYL L-CARNITINE[1] Levocarnitine[1] D02176 --[1] 97
1045PROPIONYL L-CARNITINE HYDROCHLORIDE[1] Levocarnitine[1] D02176 --[1] 97
1046Propionyl-L-Carnitine[2] Levocarnitine,
Levocarnitine propionate		[1] D02176 --[1] 97
1047Propionylcarnitinhydrochlorid----[1] 97
1048Propiverine[1] Propiverine[1] D08441 [9] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[43] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
1049Propiverine Hydrochloride[1] Propiverine[1] D08441 [9] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[43] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
1050PROPOFOL[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[8] 6, 21, 22, 34, 46, 70, 98, 296
1051Propofol Injection[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 70
1052Propofol-Lipuro[1] Propofol[1] D00549 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 6
1053Propolipid----[1] 46
1054Proposed INN - FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
1055Propranolol[1] Propranolol[1] D08443 [3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 158, 167, 227, 278
1056Propranolol HCl CF 40 mg tablet[1] Propranolol[1] D08443 [3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
1057Propranolol treatment[1] Propranolol[1] D08443 [3] ADRB1,
ADRB2,
ADRB3 💬		[12] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 227
1058Propsoed INN - FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
1059Propylene glycol[1] Propylene glycol[1] D00078 --[1] 51
1060ProSavin----[1] 6
1061PROSCAR*30CPR RIV 5MG[1] Finasteride[1] D00321 [1] SRD5A2 💬[3] Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬[1] 6
1062Prostacyclin[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
1063Prostacyclin Receptor Agonist[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
1064Prostanoids----[1] 51
1065PROTEASA----[1] 299
1066PROTEASE----[1] 299
1067Protease inhibitor----[1] 265
1068Protease inhibitors----[1] 265
1069ProTectis----[1] 66
1070Protein----[2] 46, 67
1071Protein intake----[1] 240
1072Protein-carbohydrate supplementation----[1] 113
1073Proteína recombinante estimulante de la megacariopoyesis----[1] 63
1074Prothrombin[1] Prothrombin---[1] 288
1075Prothrombin Complex Concentrate[2] Factor IX Complex (Human),
Prothrombin		---[1] 288
1076Proton pump inhibitor (PPI)----[1] 298
1077Prototype capsule GDC-0134[1] GDC-0134---[1] 2
1078Provigil[1] Modafinil[1] D01832 --[2] 13, 113
1079Provigil (modafinil)[1] Modafinil[1] D01832 --[1] 13
1080PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE[1] Modafinil[1] D01832 --[1] 113
1081PROZAC----[1] 17
1082PRP----[1] 90
1083PRP injection----[1] 53
1084PRTX-100----[1] 46
1085PRTX-100 (Staphylococcal protein A)[1] Bevifimod---[1] 63
1086PRTX-100 at 1.5 mcg/kg----[1] 46
1087PRTX-100 at 12.0 mcg/kg----[1] 46
1088PRTX-100 at 240 mcg----[1] 46
1089PRTX-100 at 3.0 mcg/kg----[1] 46
1090PRTX-100 at 420 mcg----[1] 46
1091PRTX-100 at 6.0 mcg/kg----[1] 46
1092PRU-PLA-PLA-PRU----[1] 99
1093PRU-PLA-PRU-PLA----[1] 99
1094PRUCALOPRIDE[1] Prucalopride[1] D09205 [1] HTR4 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[3] 13, 51, 96
1095PRUCALOPRIDE SUCCINATE[1] Prucalopride[1] D09205 [1] HTR4 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[1] 51
1096PRV-300----[1] 97
1097PRV-6527----[1] 96
1098PRV-6527 (JNJ-40346527)[1] JNJ-40346527---[1] 96
1099PRV-6527(JNJ-40346527)[1] JNJ-40346527---[1] 96
1100PRX-102----[1] 19
1101PRX-102 (pegunigalsidase alfa)[1] Pegunigalsidase alfa[1] D11685 --[1] 19
1102PRX-102 1 mg/kg every 2 weeks----[1] 19
1103PRX-102 2 mg/kg every 4 weeks----[1] 19
1104PRX-112----[1] 19
1105PRX002----[1] 6
1106PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----[1] 6
1107PRX102----[1] 19
1108PS----[2] 90, 97
1109PS-QD----[1] 97
1110PS-SP----[1] 97
1111PS128----[1] 6
1112PS188----[1] 113
1113PS188 (company code)----[1] 113
1114PS220----[1] 113
1115PS524----[1] 113
1116PsAer IgY----[1] 299
1117Pseudoephedrine[1] Pseudoephedrine[1] D08449 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1118Pseudoephedrine + 480 ml water[2] Pseudoephedrine,
Water		[2] D00001 ,
D08449 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1119Pseudoephedrine + 50 ml water[2] Pseudoephedrine,
Water		[2] D00001 ,
D08449 		[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
1120Psilocybin[1] Psilocybin---[1] 6
1121Psilocybin therapy[1] Psilocybin---[1] 6
1122Psilocybine[1] Psilocybin---[1] 6
1123Psorcutan-Ointment----[1] 36
1124PSRS11.EFS.IL2RG.pre* retroviral vector----[1] 65
1125PSRS11.EFS.IL2RG.pre* retroviral vector transduce----[1] 65
1126PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----[1] 65
1127Psyllium[1] Plantago seed[1] D05525 --[3] 6, 28, 97
1128Psyllium husk[1] Plantago seed[1] D05525 --[1] 97
1129Psyllium Husk Powder[1] Plantago seed[1] D05525 --[1] 97
1130PT320 2.0 mg----[1] 6
1131PT320 2.5 mg----[1] 6
1132PTC-0161480----[2] 246, 299
1133PTC-124----[2] 246, 299
1134PTC-C124----[2] 246, 299
1135PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----[1] 113
1136PTC124----[4] 19, 113, 246, 299
1137PTC299[1] PTC299---[1] 34
1138PTC518----[1] 8
1139PTC518 tablet 20 mg----[1] 8
1140PTC518 tablet 5 mg----[1] 8
1141PTC743----[2] 18, 21
1142PTC857----[1] 2
1143PTC857 oral solution----[1] 2
1144PTC923----[1] 240
1145PTG-100----[1] 97
1146PTG-200----[1] 96
1147PTH----[2] 65, 235
1148PTH 1-34[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[2] 65, 235
1149PTH1-84 in parent study----[1] 235
1150PTI-428[1] PTI-428---[1] 299
1151PTI-801[1] PTI-801---[1] 299
1152PTI-808----[1] 299
1153PTL201----[1] 13
1154PTR-01----[1] 36
1155PTW-002 10 mg/g gel----[1] 36
1156PU-AD----[1] 2
1157Puerarin[1] Puerarin---[1] 46
1158Puerarin injection 400 mg[1] Puerarin---[1] 46
1159Puerarin tablet 50 mg[1] Puerarin---[1] 46
1160Pulmaquin®----[1] 299
1161Pulmozyme[1] Dornase alfa[1] D03896 --[1] 299
1162Pulmozyme (dornase alfa)[1] Dornase alfa[1] D03896 --[1] 299
1163Pulmozyme (Dornase alpha)[1] Dornase alfa[1] D03896 --[1] 299
1164Pulmozyme single use ampule[1] Dornase alfa[1] D03896 --[1] 299
1165Pulmozyme®[1] Dornase alfa[1] D03896 --[1] 299
1166PUR 0110----[1] 97
1167PUR 0110 Rectal Enema----[1] 97
1168PUR 0110 Rectal Enema 1000 mg----[1] 97
1169PUR 0110 Rectal Enema 250 mg----[1] 97
1170PUR 0110 Rectal Enema 500 mg----[1] 97
1171PUR118----[1] 299
1172Puri Nethol----[1] 96
1173Puri-Nethol----[3] 86, 96, 97
1174Puri-Nethol 50 mg----[1] 96
1175Purified form of the lysosomal enzyme iduronate-2-sulfatase----[1] 19
1176Purified Vero Cell Vaccine)----[1] 65
1177PURINETHOL[1] Mercaptopurine[2] D00161 ,
D04931 		[1] HPRT1 💬[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 96
1178PURINETHOL - 50 MG COMPRESSE25 COMPRESSE[1] Mercaptopurine[2] D00161 ,
D04931 		[1] HPRT1 💬[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 96
1179PV----[1] 97
1180PXL065----[1] 20
1181PXL770----[1] 20
1182PXT002331----[1] 6
1183PXT002331 - 20mg----[1] 6
1184PXT002331 - dose 1----[1] 6
1185PXT002331 - dose 2----[1] 6
1186PXT3003----[1] 10
1187PXT3003 Dose 1----[1] 10
1188PXT3003 Dose 2----[1] 10
1189PXT3003 Dose 2 (equivalent to twice Dose 1)----[1] 10
1190PXT3003 High Dose----[1] 10
1191PXT3003 Intermediate Dose----[1] 10
1192PXT3003 Low dose----[1] 10
1193PYM50028----[1] 6
1194Pyrazole[1] Pyrazole---[1] 58
1195Pyridostigmine[1] Pyridostigmine---[4] 3, 6, 11, 256
1196Pyridostigmine Bromide[1] Pyridostigmine---[3] 3, 6, 256
1197Pyridostigmine, Prednisone, Tacrolimus[3] Prednisone,
Pyridostigmine,
Tacrolimus		[3] D00107 ,
D00473 ,
D08556 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11
1198Pyridostigmine, Tacrolimus[2] Pyridostigmine,
Tacrolimus		[2] D00107 ,
D08556 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 11
1199PYRIDOXINE[1] Pyridoxine[1] D08454 --[3] 93, 145, 320
1200Pyridoxine 10mg[1] Pyridoxine[1] D08454 --[1] 93
1201Pyridoxine 10mg BP[1] Pyridoxine[1] D08454 --[1] 93
1202Pyridoxine plus prednisolone[2] Prednisolone,
Pyridoxine		[2] D00472 ,
D08454 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 145
1203PYRIMETHAMINE[1] Pyrimethamine[1] D00488 --[4] 2, 4, 19, 65
1204Pyrophosphate----[1] 51
1205Pyrrolidine[1] Pyrrolidine---[2] 28, 97
1206Pyruvate, creatine, niacinamide[2] Creatine,
Nicotinamide		[1] D00036 --[1] 5
1207PyVST----[1] 25
1208PZN 8881655(RochePharma AG)----[1] 85